A tiny fossil overlooked for decades at La Brea Tar Pits has turned out to belong to a species previously unknown to science.

Researchers from the University of Technology Sydney (UTS), Harvard, and Henan universities have developed a ‘double punch’ nanozyme platform intended to tackle both problems using the same smart ...

A Neanderthal-derived growth hormone receptor still carried by some people today appears to amplify growth-related signals in cells.

The pain and urgent need to urinate during a urinary tract infection (UTI) may be more than unpleasant symptoms. Australian researchers have identified a little-understood group of nerves near the ...

The researchers made the measurement at the Chooz nuclear power plant in northern France. About 400 meters from its two reactor cores, the Double Chooz detector sits underground and contains more than ...

Spacecraft measurements may make highly organized particle motion in Earth’s radiation belts look random, potentially obscuring the physics driving these hazardous environments. Credit: Shutterstock ...

An illustration of the experimental concept shows how researchers study phases in quantum material. In the background, the uniform blue stripes are the dominant order, and the subtle red stripe ...

This image shows the host galaxy of the recently detected supernova SN 2026gzf. This supernova was first detected by the Einstein Probe on March 21, 2026. This archival image of the host galaxy from ...

People generally describe dozens or hundreds of miniature figures measuring roughly 3 to 30 centimeters (about 1.2 to 11.8 inches) tall. About 90% characterize them as elves, clowns, or other ...

The nucleus of the cells of interest has been labeled scarlet. Credit: University of Manchester Researchers found that a little-known group of immune cells is crucial for keeping cancer-fighting T ...

Europe is about to experience a total solar eclipse, and people around the world will be able to watch it live. The European ...

A prescription THC drug made PTSD nightmares disappear for more than one-third of patients in a promising clinical trial.